It was indicated that high Kindlin-2 expression in cancer patients was significantly associated with a poor outcome (for OS, HR 1.66, 95% CI 1.44–1.92, P < 0.0001) (Fig. 2 and Table 3). The gene discussed is FERMT2; the disease is cancer.